(Q44248769)

1 December 2017

title

Staphylococci as uropathogens-frequency of isolation in hospitalized patients and sensitivity to antimicrobial agents (English)

1 reference

1 December 2017

1 reference

Guirguitzova B

1

1 reference

1 December 2017

Chankova D

series ordinal

2

1 reference

1 December 2017

Zozikov B

series ordinal

3

1 reference

1 December 2017

publication date

1 October 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

36

1 reference

1 December 2017

issue

5

1 reference

1 December 2017

page(s)

341-347

1 reference

Enterococcus species in urinary tract infection

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Streptococcus agalactiae as a urinary tract pathogen in males and non-pregnant females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Urinary tract infections in females.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Coagulase-negative staphylococci: role as pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Staphylococcus aureus: a well-armed pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Diagnosis and management of urinary tract infection in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Susceptibility of clinical bacterial isolates to ciprofloxacin in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Epidemiological typing of clinically significant strains of coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Emergence of vancomycin resistance in coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4401%2802%2900124-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-4401(02)00124-9

1 reference

1 December 2017

1 reference